Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management.

Literature DB >> 10988204

Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management.

J E Michaelson¹, S M Aguayo, J Roman.

Abstract

Entities: Disease

Mesh：

Substances：
Glucocorticoids

Year: 2000 PMID： 10988204 DOI： 10.1378/chest.118.3.788

Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis.

Authors: H Satoh; H Ishikawa; Y T Yamashita; M Ohtsuka; K Sekizawa
Journal: Thorax Date: 2002-03 Impact factor: 9.139

Review 2. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Authors: Talmadge E King
Journal: Trans Am Clin Climatol Assoc Date: 2004

3. Protective Effects of Chymostatin on Paraquat-Induced Acute Lung Injury in Mice.

Authors: Chen Yang; Hong-Wei Song; Wei Liu; Xue-Song Dong; Zhi Liu
Journal: Inflammation Date: 2018-02 Impact factor: 4.092

Review 4. Therapeutic update in idiopathic pulmonary fibrosis.

Authors: Andrew L Chan; Rokhsara Rafii; Samuel Louie; Timothy E Albertson
Journal: Clin Rev Allergy Immunol Date: 2013-02 Impact factor: 8.667

5. Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.

Authors: Masaaki Sumi; Hiroaki Satoh; Katsunori Kagohashi; Hiroichi Ishikawa; Kiyohisa Sekizawa
Journal: J Clin Lab Anal Date: 2005 Impact factor: 2.352

6. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process.

Authors: Carlos Henrique Chirnev Felício; Edwin Roger Parra; Vera Luiza Capelozzi
Journal: Lung Date: 2007-02-09 Impact factor: 2.584

Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management.

1. Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis.

Review 2. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

3. Protective Effects of Chymostatin on Paraquat-Induced Acute Lung Injury in Mice.

Review 4. Therapeutic update in idiopathic pulmonary fibrosis.

5. Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.

6. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process.

7. Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

8. A review of current and novel therapies for idiopathic pulmonary fibrosis.

9. Pathway‑based detection of idiopathic pulmonary fibrosis at an early stage.

Review 10. Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.